• Users Online: 639
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs

Heinrichs Marc Tobias, May Robert Justin, Heider Fabian, Reimers Tobias, B. Sy Sherwin Kenneth, Peloquin Charles Arthur, Derendorf Hartmut

Year : 2018| Volume: 7| Issue : 2 | Page no: 156-161

   This article has been cited by
 
1 Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function
Milan Dak, Veronika Šlachtová, Marek Šebela, Václav Bazgier, Karel Berka, Natalia Smiejkowska, Lauren Oorts, Davie Cappoen, Lucie Brulíková
European Journal of Medicinal Chemistry. 2022; : 114831
[Pubmed]  [Google Scholar] [DOI]
2 Tailored therapeutic release from polycaprolactone-silica hybrids for the treatment of osteomyelitis: antibiotic rifampicin and osteogenic silicates
Lukas Gritsch, Henri Granel, Nicolas Charbonnel, Edouard Jallot, Yohann Wittrant, Christiane Forestier, Jonathan Lao
Biomaterials Science. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Elucidation of the signalling pathways for enhanced exosome release from Mycobacterium -infected macrophages and subsequent induction of differentiation
Arpana Singh, Kaushik Das, Sampali Banerjee, Prosenjit Sen
Immunology. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Synthesis and Evaluation of Marine Natural Product-Inspired Meroterpenoids with Selective Activity toward Dormant Mycobacterium tuberculosis
Anshupriya Si, Alexander D. Landgraf, Sandra Geden, Steven J. Sucheck, Kyle H. Rohde
ACS Omega. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Exposure to Nepalese Propolis Alters the Metabolic State of Mycobacterium tuberculosis
Rafal Sawicki, Jaroslaw Widelski, Piotr Okinczyc, Wieslaw Truszkiewicz, Joanna Glous, Elwira Sieniawska
Frontiers in Microbiology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
6 Elevated IL-35 level and iTr35 subset increase the bacterial burden and lung lesions in Mycobacterium tuberculosis-infected mice
Fangliu Yu, Xinying Zhu, Qingdeng Li, Wenqin Xu, Yunxing Gao, Yufeng Wen, Qiong Zhang, Jun Dou
Open Life Sciences. 2022; 17(1): 312
[Pubmed]  [Google Scholar] [DOI]
7 Cyclic-di-AMP Phosphodiesterase Elicits Protective Immune Responses Against Mycobacterium tuberculosis H37Ra Infection in Mice
Yanzhi Lu, Huanhuan Ning, Jian Kang, Guangchun Bai, Lei Zhou, Yali Kang, Zhengfeng Wu, Maolin Tian, Junhao Zhao, Yueyun Ma, Yinlan Bai
Frontiers in Cellular and Infection Microbiology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
8 Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole
Martin Juhás, Andrea Bachtíková, Daria Elzbieta Nawrot, Paulína Hatoková, Vinod Sukanth Kumar Pallabothula, Adéla Diepoltová, Ondrej Jandourek, Pavel Bárta, Klára Konecná, Pavla Paterová, Vít Šesták, Jan Zitko
Pharmaceuticals. 2022; 15(5): 580
[Pubmed]  [Google Scholar] [DOI]
9 Synthesis, Characterization and Biological Evaluation of New 3,5-Disubstituted-Pyrazoline Derivatives as Potential Anti-Mycobacterium tuberculosis H37Ra Compounds
Kok Tong Wong,Hasnah Osman,Thaigarajan Parumasivam,Unang Supratman,Mohammad Tasyriq Che Omar,Mohamad Nurul Azmi
Molecules. 2021; 26(7): 2081
[Pubmed]  [Google Scholar] [DOI]
10 Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides
Ghada Bouz,Sarah Bouz,Ondrej Jandourek,Klára Konecná,Pavel Bárta,Jarmila Vinšová,Martin Doležal,Jan Zitko
Pharmaceuticals. 2021; 14(8): 768
[Pubmed]  [Google Scholar] [DOI]
11 Activity of Pyrazinamide against Mycobacterium tuberculosis at Neutral pH in PZA-S1 Minimal Medium
Wanliang Shi
Antibiotics. 2021; 10(8): 909
[Pubmed]  [Google Scholar] [DOI]
12 Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents
Jana Curillová, Mária Pechácová, Tereza Padrtová, Daniel Pecher, Šárka Mascaretti, Josef Jampílek, Ludmila Pašková, František Bilka, Gustáv Kovác, Ivan Malík
Applied Sciences. 2021; 12(1): 300
[Pubmed]  [Google Scholar] [DOI]
13 Synthesis, Characterization and Antimycobacterial Activity of Phenanthrenequinone Thiosemicarbazones and their Ruthenium and Zinc Complexes
Ashok K. Singh,Shailendra K. Singh,Kavita Dhariyal,Ram Kumar,Amarendra Kumar,Sudheer K. Singh
Asian Journal of Chemistry. 2021; 33(5): 983
[Pubmed]  [Google Scholar] [DOI]
14 Improved solubility and stability of rifampicin as an inclusion complex of acyclic cucurbit[n]uril
Hui Liu,Zu-Zheng He,Lei Yu,Jun Ma,Xue-Pin Jin
Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
15 A sensitive EZMTT method provides microscale, quantitative and high-throughput evaluation of drug efficacy in the treatment of Mycobacterium tuberculosis infectious diseases
Li Xie,Zhao Chen,Wei Liu,Dongshi Gu,Yan Yu,Xinrou Chen,Yefei Wu,Ning Xu,Jie Xie,Gang Zhao,Benfang Helen Ruan
Journal of Microbiological Methods. 2021; 181: 106136
[Pubmed]  [Google Scholar] [DOI]
16 Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv
Farheen Fatma,Dinesh K. Tripathi,Mrigank Srivastava,Kishore K. Srivastava,Ashish Arora
Tuberculosis. 2021; : 102054
[Pubmed]  [Google Scholar] [DOI]
17 Total Synthesis of Tetrahydrolipstatin, Its Derivatives, and Evaluation of Their Ability to Potentiate Multiple Antibiotic Classes against Mycobacterium Species
Saniya S. Khan,Thanuja D. Sudasinghe,Alexander D. Landgraf,Donald R. Ronning,Steven J. Sucheck
ACS Infectious Diseases. 2021;
[Pubmed]  [Google Scholar] [DOI]
18 Synthesis and Evaluation of Antimycobacterial and Antiplasmodial Activities of Hirsutellide A and Its Analogues
Henok Asfaw Sahile,Maria Santos Martínez-Martínez,Melissa Dillenberger,Katja Becker,Peter Imming
ACS Omega. 2020; 5(24): 14451
[Pubmed]  [Google Scholar] [DOI]
19 Guttiferone K Exerts the Anti-inflammatory Effect on Mycobacterium Tuberculosis- (H37Ra-) Infected Macrophages by Targeting the TLR/IRAK-1 Mediated Akt and NF-?B Pathway
Qingwen Zhang,Jinxia Sun,Yan Fu,Weigang He,Yinhong Li,Hongsheng Tan,Hongxi Xu,Xin Jiang
Mediators of Inflammation. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
20 Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
Nada Lelovic,Katsuhiko Mitachi,Junshu Yang,Maddie R. Lemieux,Yinduo Ji,Michio Kurosu
The Journal of Antibiotics. 2020;
[Pubmed]  [Google Scholar] [DOI]
21 Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis
K. B. Arun,Aravind Madhavan,Billu Abraham,M. Balaji,K. C. Sivakumar,P. Nisha,R. Ajay Kumar
Antimicrobial Agents and Chemotherapy. 2020; 65(1): e00456-20
[Pubmed]  [Google Scholar] [DOI]
22 N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—the Synthesis and Biological Evaluation of Enantiomers
Martin Juhás,Lucie Kucerová,Ondrej Horácek,Ondrej Jandourek,Vladimír Kubícek,Klára Konecná,Radim Kucera,Pavel Bárta,Jirí Janoušek,Pavla Paterová,Jirí Kuneš,Martin Doležal,Jan Zitko
Molecules. 2020; 25(7): 1518
[Pubmed]  [Google Scholar] [DOI]
23 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
Weronika Ambrozkiewicz,Marta Kucerová-Chlupácová,Ondrej Jandourek,Klára Konecná,Pavla Paterová,Pavel Bárta,Jarmila Vinšová,Martin Doležal,Jan Zitko
Molecules. 2020; 25(7): 1561
[Pubmed]  [Google Scholar] [DOI]
24 Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis
Jiayun Liu,Wanliang Shi,Shuo Zhang,Xiaoke Hao,Dmitry A. Maslov,Kirill V. Shur,Olga B. Bekker,Valery N. Danilenko,Ying Zhang
Frontiers in Microbiology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
25 Inhaled Antibiotics for Mycobacterial Lung Disease
Robert J. Banaschewski,Robert J. Hofmann
Pharmaceutics. 2019; 11(7): 352
[Pubmed]  [Google Scholar] [DOI]
26 Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides: Comparative Molecular Surface Analysis
Hana Michnová,Šárka Pospíšilová,Tomáš Gonec,Iva Kapustíková,Peter Kollár,Violetta Kozik,Robert Musiol,Izabela Jendrzejewska,Ján Vanco,Zdenek Trávnícek,Alois Cížek,Andrzej Bak,Josef Jampílek
Molecules. 2019; 24(16): 2991
[Pubmed]  [Google Scholar] [DOI]
27 Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis
Zeinab G. Khalil,Timothy A. Hill,Luis M. De Leon Rodriguez,Rink-Jan Lohman,Huy N. Hoang,Norbert Reiling,Doris Hillemann,Margaret A. Brimble,David P. Fairlie,Antje Blumenthal,Robert J. Capon
Antimicrobial Agents and Chemotherapy. 2019; 63(3)
[Pubmed]  [Google Scholar] [DOI]
28 Synthesis, characterization, and in vitro evaluation of gamma radiation-induced PEGylated isoniazid
Maykel González Torres,Silvia Guzman Beltrán,Marco A. Mata Gómez,José González Valdez,Gerardo Leyva Gómez,Yaaziel Melgarejo Ramírez,Witold Brostow,Cristina Velasquillo Martínez,Joaquín Zúńiga Ramos,Rogelio Rodríguez Talavera
Electronic Journal of Biotechnology. 2019;
[Pubmed]  [Google Scholar] [DOI]
29 Electrochemistry of ring-substituted 1-hydroxynaphthalene-2-carboxanilides: Relation to structure and biological activity
Július Gajdár,Konstantina Tsami,Hana Michnová,Tomáš Gonec,Marie Brázdová,Zuzana Soldánová,Miroslav Fojta,Josef Jampílek,Jirí Barek,Jan Fischer
Electrochimica Acta. 2019; : 135485
[Pubmed]  [Google Scholar] [DOI]
30 Dose optimization of moxifloxacin and linezolid against tuberculosis using mathematical modeling and simulation
M. Tobias Heinrichs,George L. Drusano,David L. Brown,Michael S. Maynard,Sherwin K.B. Sy,Kenneth H. Rand,Charles A. Peloquin,Arnold Louie,Hartmut Derendorf
International Journal of Antimicrobial Agents. 2018;
[Pubmed]  [Google Scholar] [DOI]
31 Antimycobacterial Activity of Cinnamaldehyde in a Mycobacterium tuberculosis(H37Ra) Model
Rafal Sawicki,Joanna Golus,Agata Przekora,Agnieszka Ludwiczuk,Elwira Sieniawska,Grazyna Ginalska
Molecules. 2018; 23(9): 2381
[Pubmed]  [Google Scholar] [DOI]

 

Read this article